WEC
NTUS

Winslow Evans & Crocker’s Natus Medical Inc NTUS Stock Holding History

Winslow Evans & Crocker’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,576
Closed -$220K – 1348
2015
Q4 		$220K Buy
+4,576
New +$212K 0.06% 278
2015
Q1 		– Sell
-8,926
Closed -$322K – 1321
2014
Q4 		$322K Buy
+8,926
New +$300K 0.09% 220

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Winslow Evans & Crocker's NTUS Position: Q1 2016 in Review

Winslow Evans & Crocker sold out of Natus Medical Inc (NTUS) in Q1 2016, closing a stake of 4,576 shares — an estimated $220K sold.

Winslow Evans & Crocker first reported a position in NTUS in Q4 2014 and held it in 2 quarters. The position peaked at $322K in Q4 2014. 207 funds tracked by Wall St. Rank hold NTUS as of Q1 2016.

  • Winslow Evans & Crocker reported no remaining Natus Medical Inc position as of Q1 2016 after selling out during the quarter.
  • Winslow Evans & Crocker sold 4,576 Natus Medical Inc shares in Q1 2016, an estimated $220K.
  • Winslow Evans & Crocker first reported a position in Natus Medical Inc in Q4 2014 and held it in 2 quarters.
  • Winslow Evans & Crocker's Natus Medical Inc position peaked at $322K in Q4 2014.
  • 207 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2016.

Based on Winslow Evans & Crocker's 13F filing for Q1 2016, filed 20 Apr 2016.